Development, Validation and Evaluation of an Adult and Pediatric Eosinophilic Esophagitis Activity Index
NCT00939263 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 650
Last updated 2015-09-16
Summary
Eosinophilic Esophagitis (EoE) is a chronic inflammatory disease of the esophagus affecting children and adults. The most frequent symptoms are swallowing difficulties and thoracic pain. The disease has first been described in the 1980s and is found with rapidly increasing frequency mainly in industrialized countries. The factors that lead to EoE are until now incompletely understood, of importance, the disease is found more frequently in men and patients suffering from allergic diseases (e.g., Asthma). So far there exists no activity index to define the severity of EoE; such an index is urgently needed for future clinical trials to determine the efficacy of current and future therapies. The investigators' 3-year project, carried out in cooperation with international EoE experts, aims at the development of an activity index for adult and pediatric EoE patients that will be used in future clinical trials as well as observational studies.
Conditions
- Deglutition Disorders
- Esophageal Diseases
- Eosinophilia
Interventions
- OTHER
-
assessment of disease activity using the EEsAI
disease activity index
Sponsors & Collaborators
-
University of Bern
collaborator OTHER -
Kantonsspital Olten
collaborator OTHER -
Luzerner Kantonsspital
collaborator OTHER - collaborator OTHER
-
University of Cincinnati
collaborator OTHER -
University of Colorado, Denver
collaborator OTHER - collaborator OTHER
-
Indiana University School of Medicine
collaborator OTHER -
Philadelphia University
collaborator OTHER -
Insel Gruppe AG, University Hospital Bern
lead OTHER
Principal Investigators
-
Alain Schoepfer, MD, PD+MER1 · Department of Gastroenterology and Hepatology, Centre Hospitalier Universitaire Vaudois / CHUV
-
Alex Straumann, MD, Prof. · Praxis Römerhof, Olten, Switzerland
-
Marcel Zwahlen, PhD, Prof. · Institute for Social and Preventive Medicine, University of Bern
-
Claudia Kuehni, MD MSc, Prof. · Institute for Social and Preventive Medicine, University of Bern
-
Christian Bussmann, MD · Viollier AG
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-01-31
- Primary Completion
- 2016-07-31
- Completion
- 2016-12-31
Countries
- United States
- Canada
- Switzerland
- United Kingdom
Study Locations
More Related Trials
-
Phenotypic Characterization and Biomarkers Investigation for Eosinophilic Esophagitis in Pediatric Patients
NCT03069573 ·Status: COMPLETED
-
Risk Factors and Biomarkers for Diagnosis and Treatment of EoE
NCT01988285 ·Status: ACTIVE_NOT_RECRUITING
-
Non-endoscopic Tracking of Disease Activity in Eosinophilic Esophagitis
NCT03834298 ·Status: WITHDRAWN ·Phase: NA
-
Allergy Immunotherapy in the Management of Eosinophilic Esophagitis
NCT01685034 ·Status: WITHDRAWN ·Phase: NA
-
Comparison of Esomeprazole to Aerosolized, Swallowed Fluticasone for Eosinophilic Esophagitis
NCT00123656 ·Status: COMPLETED ·Phase: PHASE2
-
Routine Screening for Eosinophilic Esophagitis in Patients Presenting With Dysphagia
NCT01028235 ·Status: UNKNOWN
-
Use of Esophageal String Test to Understand Symptoms, Inflammation, and Function in Eosinophilic Esophagitis
NCT03305653 ·Status: COMPLETED ·Phase: NA
-
Evaluating Adrenal Insufficiency in Adults With Eosinophilic Esophagitis on Chronic Swallowed Topical Steroids
NCT05246085 ·Status: UNKNOWN
-
Local Clinical and Immunological Responses in Eosinophilic Esophagitis (EoE) Patients, Role of Mucosal Barrier Function and Type II Inflammation
NCT07012928 ·Status: RECRUITING
-
The Role Of Gastroesophageal Reflux Disease (GERD) in Eosinophilic Esophagitis
NCT00728481 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Outcome of Children With Eosinophilic Esophagitis
NCT06190080 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Eating With Eosinophilic Esophagitis (EoE)
NCT03581838 ·Status: COMPLETED
-
Prospective Multicenter Nationwide Registry of Children With Eosinophilic Esophagitis
NCT03858426 ·Status: UNKNOWN
-
Predictors of Proton Pump Inhibitor (PPI) Response in Eosinophilic Esophagitis
NCT01479231 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Metabolomic Profiling of Eosinophilic Esophagitis
NCT03803527 ·Status: WITHDRAWN ·Phase: NA
-
Prevalence of Food Allergies in a Cohort of Adult Patients With Eosinophilic Esophagitis
NCT01631591 ·Status: COMPLETED
-
Proton Pump Inhibitor (PPI) Responsive Eosinophilic Esophagitis EoE: Gastroesophageal Reflux Disease (GERD) or Eosinophilic Esophagitis (EoE)?
NCT01865825 ·Status: COMPLETED
-
The Effect of Sucralfate Slurry in Patients With Eosinophilic Esophagitis
NCT02353078 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Changes in Esophageal Distensibility With Proton Pump Inhibitors in Patients With Esophageal Eosinophilia: A Pilot Study
NCT03312686 ·Status: RECRUITING
-
Swallowing Characteristics of Pediatric Patients With Eosinophilic Esophagitis
NCT04704752 ·Status: COMPLETED
-
Esophageal String Test in Eosinophilic Esophagitis
NCT02008903 ·Status: ACTIVE_NOT_RECRUITING
-
Food Antigen in Eosinophilic Esophagitis
NCT02434705 ·Status: COMPLETED
-
The Role of HRM and Specific Biomarkers of Inflammation in the Diagnosis of Patients With Dysphagia and Suspected EoE
NCT04803162 ·Status: UNKNOWN
-
Mucosal Impedance Balloon in Diagnosis and Treatment of Eosinophilic Esophagitis (EoE)
NCT02995395 ·Status: COMPLETED
-
Fluticasone Versus Esomeprazole to Treat Eosinophilic Esophagitis
NCT00895817 ·Status: COMPLETED ·Phase: NA